Fortress Biotech, Inc. Cash Flow Statement
FBIO|11 years of annual SEC 10-K data (FY2015-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 11 fiscal years. All figures from audited SEC 10-K filings.
Fortress Biotech, Inc. used $80M in operating cash flow in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$46.0M | -$60.6M | -$86.6M | -$64.7M | -$46.5M | -$40.0M | -$84.1M | -$66.9M | -$48.4M | -$20.4M | -$37.2M |
| Depreciation & Amortization | $1.0M | $2.2M | $3.1M | $2.6M | $2.3M | $1.9M | $1.4M | $726.0K | $26.0K | $23.0K | $17.0K |
| Operating Cash Flow | -$80.2M | -$128.2M | -$179.4M | -$116.5M | -$83.7M | -$95.0M | -$98.8M | -$81.3M | -$20.4M | -$16.3M | -$29.6M |
| Capital Expenditures | - | $63.0K | $2.7M | $4.6M | $1.9M | $2.3M | $7.1M | $648.0K | $283.0K | $0 | $40.0K |
| Free Cash Flow | - | -$128.3M | -$182.1M | -$121.1M | -$85.6M | -$97.3M | -$105.9M | -$82.0M | -$20.7M | -$16.3M | -$29.7M |
| Share Buybacks | - | - | - | - | $70.0K | $0 | - | - | - | - | - |
| Dividends Paid | $694.0K | $736.0K | $749.0K | $749.0K | $237.0K | $0 | - | - | - | - | - |
| FCF Margin | - | -151.8% | -240.4% | -176.0% | -187.7% | -265.6% | -394.1% | -475.2% | -2394.1% | -1892.7% | - |